Dysregulated expression of androgen-responsive and nonresponsive genes in the androgen-independent prostate cancer xenograft model CWR22-R

Cancer Research

Volumn 60, Issue 21, 2000, Pages 6134-6141

  Amler, Lukas C ^a   Agus, David B ^b   LeDuc, Carrie ^a   Sapinoso, M Lisa ^a   Fox, William D ^b   Kern, Suzanne ^a   Lee, Dori ^a   Wang, Vivian ^a   Leysens, Maurice ^a   Higgins, Brian ^b   Martin, Jason ^a   William, William ^b   Dracopoli, Nicholas ^a   Cordon Cardo, Carlos ^b   Scher, Howard I ^b   Hampton, Garret M ^a  

^a Genos Biosciences Inc   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; CALCIUM BINDING PROTEIN; FK 506 BINDING PROTEIN; PROTEIN S100P; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GRAFT; CANCER GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; GENE CONTROL; HORMONAL REGULATION; HORMONE RESPONSIVE ELEMENT; HUMAN; HUMAN TISSUE; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; NUDE MOUSE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION;

ANDROGENS; ANIMALS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOPLASMS, HORMONE-DEPENDENT; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROSTATIC NEOPLASMS; TRANSPLANTATION, HETEROLOGOUS; UP-REGULATION;

EID: 0034326788     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Clinical states in prostate cancer: Towards a dynamic model of disease progression
2. Response of prostate cancer to anti-Her-2/neu antibody in androgen-dependent and -independent human xenograft models
3. The biologic effects of C225, a chimeric monoclonal antibody to EGFR, on human prostate carcinoma
4. Targeting bcl-2 gene to delay androgen-independent progression and enhance chemosensitivity in prostate cancer using antisense bcl-2 oligodeoxynucleotides
5. CWR22: Androgen-dependent xenograft model derived from a primary human prostatic carcinoma
6. CWR22: The first human prostate cancer xenograft with strongly androgen-dependent and relapsed strains both in vivo and in soft agar
7. Prostate cancer cell cycle regulators: Response to androgen withdrawal and development of androgen independence
8. Changes in cyclln dependent kinase inhibitors p21 and p27 during the castration induced regression of the CWR22 model of prostatic adenocarcinoma
9. Loss of heterozygosity in cervical carcinoma: Subchromosomal localization of a putative tumor-suppressor gene to chromosome 11q22-q24
10. BTG-1, a member of a new family of antiproliferative genes
11. Cloning of the putative tumor suppressor gene for hereditary multiple exostoses (EXT1)
12. Surface-epitope masking and expression cloning identifies the human prostate carcinoma tumor antigen gene PCTA-I a member of the galectin gene family
13. Identification of TRACs (T3 receptor-associating cofactors), a family of cofactors that associate with, and modulate the activity of, nuclear hormone receptors
14. Cloning and characterization of a compressor and potential component of the nuclear hormone receptor repression complex
15. Recent advances in understanding thyroid hormone receptor coregulators
16. Altered proliferative and metastatic potential associated with increased expression of syndecan-1
17. Integrin α 6 expression in human prostate carcinoma cells is associated with a migratory and invasive phenotype in vitro and in vivo
18. Androgen receptor expression in androgen-independent prostate cancer is associated with increased expression of androgen-regulated genes
19. Serial analysis of gene expression
20. Quantitative monitoring of gene expression patterns with a complementary DNA microarray
21. Expression monitoring by hybridization to high-density oligonucleotide arrays
22. Down-regulation of T1A12/mac25, a novel insulin-like growth factor binding protein related gene, is associated with disease progression in breast carcinomas
23. A follistatin-like gene, mac25, may act as a growth suppressor of osteosarcoma cells
24. A Smad transcriptional coreppressor
25. Transforming growth factor-β-stimulated clone-22 is a member of a family of leucine zipper proteins that can homo- and heterodimerize and has transcriptional repressor activity
26. Down-regulation of TSC-22 (transforming growth factor β-stimulated clone 22) markedly enhances the growth of a human salivary gland cancer cell line in vitro and in vivo
27. Regulation of SLOOP by androgen
28. Steroid receptor interactions with heat shock protein and immunophilin chaperones
29. Triiodothyronine modulates growth, secretory function and androgen receptor concentration in the prostatic carcinoma cell line LNCaP
30. Interactive effects of triiodthyronine and androgens on prostate cell growth and gene expression
31. Hormone therapy failure in human prostate cancer: Analysis by complementary DNA and tissue microarrays
32. Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer
33. A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase
34. Evidence for clonal outgrowth of androgen-independent prostate cancer cells from androgen-dependent tumors through a twostep process